INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 114 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2018. The put-call ratio across all filers is 0.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $3,753,000 | +96.6% | 812,262 | +48.9% | 0.01% | +100.0% |
Q4 2018 | $1,909,000 | -34.5% | 545,487 | +88.7% | 0.00% | -25.0% |
Q3 2018 | $2,913,000 | +136.4% | 289,013 | +69.9% | 0.00% | +100.0% |
Q2 2018 | $1,232,000 | +909.8% | 170,104 | +1235.9% | 0.00% | – |
Q4 2017 | $122,000 | -18.1% | 12,733 | -24.1% | 0.00% | – |
Q3 2017 | $149,000 | -93.5% | 16,776 | -92.3% | 0.00% | -100.0% |
Q1 2017 | $2,285,000 | -26.3% | 217,385 | -35.5% | 0.00% | -33.3% |
Q4 2016 | $3,102,000 | +18.4% | 337,217 | +51.8% | 0.01% | +50.0% |
Q3 2016 | $2,620,000 | -31.6% | 222,205 | -25.0% | 0.00% | -55.6% |
Q2 2016 | $3,833,000 | -24.0% | 296,228 | -6.1% | 0.01% | -30.8% |
Q1 2016 | $5,046,000 | +60.2% | 315,552 | +186.9% | 0.01% | +85.7% |
Q4 2015 | $3,149,000 | +91.7% | 109,995 | +140.5% | 0.01% | +133.3% |
Q2 2015 | $1,643,000 | -84.5% | 45,731 | -75.0% | 0.00% | -85.0% |
Q1 2015 | $10,634,000 | -59.4% | 182,937 | -70.6% | 0.02% | -64.3% |
Q4 2014 | $26,196,000 | -12.6% | 621,350 | -19.6% | 0.06% | -26.3% |
Q3 2014 | $29,973,000 | +741.5% | 772,896 | +577.7% | 0.08% | +660.0% |
Q2 2014 | $3,562,000 | -6.7% | 114,046 | +23.7% | 0.01% | -9.1% |
Q1 2014 | $3,819,000 | +663.8% | 92,179 | +613.7% | 0.01% | +450.0% |
Q4 2013 | $500,000 | -68.2% | 12,916 | -71.3% | 0.00% | -60.0% |
Q3 2013 | $1,573,000 | – | 44,943 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 8,912,072 | $142,504,000 | 2.66% |
Antipodean Advisors LLC | 342,294 | $5,473,000 | 2.48% |
JW Asset Management, LLC | 221,538 | $3,542,000 | 2.31% |
Parametrica Management Ltd | 33,562 | $537,000 | 1.92% |
12 West Capital Management LP | 623,791 | $9,974,000 | 1.39% |
Folger Hill Asset Management LP | 1,418,138 | $22,676,000 | 1.27% |
Bellevue Group AG | 281,000 | $4,493,000 | 0.82% |
Plymouth Lane Capital Management, LLC | 55,300 | $884,000 | 0.78% |
Orbimed Advisors | 4,557,740 | $72,878,000 | 0.77% |
DIALECTIC CAPITAL MANAGEMENT, LP | 79,550 | $1,272,000 | 0.60% |